Latest Insider Transactions at Lexicon Pharmaceuticals, Inc. (LXRX)
This section provides a real-time view of insider transactions for Lexicon Pharmaceuticals, Inc. (LXRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of LEXICON PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of LEXICON PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
147,339
+6.07%
|
$1,768,068
$12.22 P/Share
|
|
May 31
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
147,339
+6.47%
|
$1,620,729
$11.62 P/Share
|
|
May 30
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
147,339
+6.92%
|
$1,473,390
$10.32 P/Share
|
|
May 29
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
147,339
+7.43%
|
$1,326,051
$9.84 P/Share
|
|
May 25
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
138,700
+7.59%
|
$1,248,300
$9.62 P/Share
|
|
Nov 17
2017
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
50,000
+3.13%
|
$450,000
$9.85 P/Share
|
|
Nov 15
2017
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
130,727
+8.02%
|
$1,307,270
$10.21 P/Share
|
|
Nov 14
2017
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
215,133
+13.58%
|
$1,936,197
$9.47 P/Share
|
|
Nov 13
2017
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
215,133
+15.71%
|
$1,936,197
$9.75 P/Share
|
|
Nov 10
2017
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
145,680
+13.43%
|
$1,311,120
$9.74 P/Share
|